Expert Warned Against GLP-1 Macro-Dosing Risks

Dr. Will Cole cautioned that high doses of GLP-1 weight-loss drugs may suppress natural hunger cues.

Updated on Sept. 28, 2026 in Weight Loss

Bold vector editorial illustration showing a balance scale weighing a soft organic sphere against a heavy geometric cube, representing metabolic health. — Dr. Will Cole warned that high-dose GLP-1 weight-loss medications may suppress natural hunger cues, potentially masking underlying metabolic health issues. AI Illustration. Upload story photo >

Live Poll

Do you believe long-term lifestyle changes are more important for metabolic health than weight-loss medications?

Dr. Will Cole has raised concerns regarding the use of macro-dosing GLP-1 medications for weight loss in the United States. He argues that this approach may inadvertently shut down healthy hunger signals.

Why it matters

The expert claims that society increasingly favors quick pharmacological fixes over sustained lifestyle changes. These medications can reduce food noise, but reliance on them without addressing underlying metabolic factors remains a concern.

National health data indicates that 93% of U.S. adults are metabolically unhealthy, while only 7% maintain optimal metabolic health. This disparity highlights the potential reliance on pharmaceutical interventions for weight management.

The players

Dr. Will Cole

A functional medicine practitioner and co-author of the book Heal Your Cells who focuses on metabolic health.

The details

GLP-1 medications function by reducing food cravings often referred to as food noise. By potentially overriding the body's natural hunger cues through macro-dosing, these treatments may mask deeper metabolic issues. Improving overall metabolic health requires a focus on sustained lifestyle modifications rather than relying solely on medication.

September 28, 2026: The warning was publicized.

Health Landscape

This warning sits within the broader debate over how to treat the 93% of the U.S. population that is metabolically unhealthy. It highlights a departure from standardized care that prioritizes medication, advocating instead for a return to lifestyle-focused metabolic interventions.

If you are using GLP-1 medications, consider discussing the balance between these drugs and your long-term metabolic health goals with your doctor. Focus on tracking your sustainable lifestyle habits alongside any pharmacological treatment plans.

The takeaway

While GLP-1 medications can effectively reduce food cravings, relying on them exclusively may hinder your ability to address fundamental metabolic health. Ask your physician how to integrate these treatments with evidence-based lifestyle changes to support long-term wellness.